Engager Therapy News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Engager Therapy. Real-time updates on events, politics, business and more.

Dragonfly, AbbVie partner to develop immune-mediated disease therapies

April 22, 2022

Dragonfly Therapeutics and AbbVie expanded their partnership to develop immunotherapies for new targets in fibrotic and autoimmune diseases.

Jonathon Sedgwick Bristol Myers Squibb Abbvie Inc Abbvie Discovery Research Engager Therapy Vie Discovery Research

Source: pharmaceutical-technology.com

Dragonfly Therapeutics Expands Collaboration With AbbVie To Develop Novel Immunotherapies

April 20, 2022

WASHINGTON (dpa-AFX) - Biotechnology company Dragonfly Therapeutics, Inc. announced Wednesday an expansion of its existing collaboration in oncology and autoimmune disease with peer AbbVie, Inc.

United States Therapeutics Inc Abbvie Inc Dragonfly Therapeutics Engager Therapy

Source: finanznachrichten.de

Dragonfly Therapeutics Announces Multi-Target Expansion of its Research Collaboration with AbbVie to Develop Novel Therapeutic Candidates for Immune-Mediated Diseases

April 20, 2022

/PRNewswire/ -- Dragonfly Therapeutics, Inc. ("Dragonfly"), a biotechnology company developing novel immunotherapies that harness the innate immune system to...

Jonathon Sedgwick Anne Deconinck Therapeutics Inc Global Head Of Discovery Research At Abbvie Engager Therapy Dragonfly Therapeutics

Source: prnewswire.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Engager Therapy News Today

Dragonfly, AbbVie partner to develop immune-mediated disease therapies

Dragonfly Therapeutics Expands Collaboration With AbbVie To Develop Novel Immunotherapies

Dragonfly Therapeutics Announces Multi-Target Expansion of its Research Collaboration with AbbVie to Develop Novel Therapeutic Candidates for Immune-Mediated Diseases

Explore More Categories